Skip to Content

Join the 'Reslizumab' group to help and get support from people like you.

Reslizumab News

New Biologic Drug Tackles Hard-to-Control Asthma

Posted 7 Sep 2016 by

WEDNESDAY, Sept. 7, 2016 – A new injectable drug reduces flare-ups in patients with severe asthma that is not controlled by steroid inhalers alone, two new trials show. The drug, benralizumab, is a biologic that works by killing white blood cells called eosinophils. These are present in large numbers in such patients, and they have been linked to severe asthma. If approved by the U.S. Food and ...

Cinqair Approved for Severe Asthma

Posted 23 Mar 2016 by

WEDNESDAY, March 23, 2016 – Cinqair (reslizumab) has been approved by the U.S. Food and Drug Administration to treat severe asthma among adults 18 and older. The drug is to be used in combination with other medications, the agency noted. In a Wednesday news release, the agency said that more than 22 million people in the United States have asthma, which leads to more than 400,000 ...

FDA Approves Cinqair (reslizumab) to Treat Severe Asthma

Posted 23 Mar 2016 by

March 23, 2016 – The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines. Asthma is a chronic disease that causes ...

Ask a Question

Further Information

Related Condition Support Groups


Related Drug Support Groups


Reslizumab Patient Information at